EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Overlapping airway diseases and risk of major adverse cardiovascular events: a UK biobank prospective cohort study

Pingsheng Hu, Linhua Kuang, Di-En Yan, Jianming Wu, Keyang Zheng, Junyu Pei, Wenqi He

Frontiers in Cardiovascular Medicine · 29.07.2026 · 13

DOI: 10.3389/fcvm.2026.1875022 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 29.07.2026. Verfasst von Pingsheng Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Ji'an Central Hospital, Ji'an, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis frequently coexist, but the cardiovascular implications of their overlap phenotypes have not been systematically quantified in large prospective cohorts.

Methods

Among 407,127 UK Biobank participants free of cardiovascular disease at baseline, we classified asthma, COPD, and bronchiectasis into eight mutually exclusive phenotypes and used Cox proportional hazards regression to assess their associations with the first occurrence of major adverse cardiovascular events (MACE, comprising myocardial infarction, stroke, and cardiovascular death). We further tested for a dose–response relationship and effect modification by sex.

Results

Over a median follow-up of 14 years, 19,660 MACE occurred. All overlap phenotypes carried elevated MACE risk, with asthma–bronchiectasis showing the highest risk (hazard ratio [HR] 3.23, 95% confidence interval [CI] 1.94–5.36); this association remained stable across sequential confounder adjustments, indicating that the risk was independent of traditional cardiovascular factors. MACE risk rose stepwise with the number of concurrent airway diseases (HRs of 1.00, 1.15, and 1.79 for 0, 1, and 2 diseases; P -trend = 1.45 × 10 −23 ). Sex significantly modified this association (P-interaction = 0.0015), with consistently stronger risk elevations in women than in men across all principal phenotypes.

Conclusions

Overlapping airway diseases substantially elevate MACE risk in a dose-dependent manner, with risk most pronounced in women. Asthma–bronchiectasis emerged as a previously under-recognised high-risk combination. These findings support integrating airway comorbidity into cardiovascular risk stratification.

Schlagwörter

Stichwörter der Autor:innen

UK biobankairway disease overlapasthmabronchiectasischronic obstructive pulmonary diseasemajor adverse cardiovascular eventsprospective cohort studysex differences

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Ji'an Central Hospital, Ji'an, China.
  • Department of Cardiology, Ji'an Central Hospital, Ji'an, China.
  • Department of Endocrinology, Ji'an Central Hospital, Ji'an, China.
  • Department of Intensive Care Unit, Ji'an Central Hospital, Ji'an, China.
  • Department of General Practice, Beijing Nuclear Industry Hospital, Beijing, China.
  • Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.

Zitieren

APA

Hu, P., Kuang, L., Yan, D. E., Wu, J., Zheng, K., Pei, J., & He, W. (2026). Overlapping airway diseases and risk of major adverse cardiovascular events: a UK biobank prospective cohort study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1875022

Vancouver

Hu P, Kuang L, Yan DE, Wu J, Zheng K, Pei J, et al. Overlapping airway diseases and risk of major adverse cardiovascular events: a UK biobank prospective cohort study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1875022

BibTeX
@article{Hu2026,
  author = {Hu, Pingsheng and Kuang, Linhua and Yan, Di-En and Wu, Jianming and Zheng, Keyang and Pei, Junyu and He, Wenqi},
  title = {Overlapping airway diseases and risk of major adverse cardiovascular events: a UK biobank prospective cohort study},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1875022}
}
Kostenlos starten →